United Kingdom · Question · Written question
UIN 7196
Coronavirus: Immunotherapy
Original
Introduced
25 May 2021
Last action
2 June 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
2 June 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the extent of the UK’s access to monoclonal antibody therapies as an alternative to covid-19 vaccines.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 May 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the extent of the UK’s access to monoclonal antibody therapies as an alternative to covid-19 vaccines.
Source: Commons
2 June 2021
Answer
The Therapeutics Taskforce continues to monitor a range of COVID-19 therapeutics, including monoclonal antibodies, aimed at different stages of the treatment pathway. There has been a collaboration with the Vaccines Taskforce to assess the potential of ne...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-05-25/7196
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1327751
- uk · wq-1327751 · source updated 2 June 2021